Aprea Therapeutics, Inc. (APRE)
Operating Income Growth
-19.02%
Quarterly · Period ending:
APRE Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-19.02%period ending
Latest reported-19.02%period ending
APRE Quarterly Operating Income YoY % (-146.30% → -19.02%)
Year-over-year change
High-resolution chart · PNG
APRE operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| -19.0216% | |
| 16.0361% | |
| 18.0702% | |
| 23.9108% | |
| 11.9355% | |
| -29.7146% | |
| 12.2148% | |
| -16.2983% | |
| -5.3467% | |
| 31.8622% | |
| -38.5914% | |
| 16.1265% | |
| 96.2914% | |
| 42.7545% | |
| 66.1293% | |
| 55.4612% | |
| -884.8935% | |
| 20.7544% | |
| 44.9592% | |
| 22.9183% | |
| 30.9603% | |
| 14.1747% | |
| -18.7286% | |
| -69.4888% | |
| -143.8515% | |
| -169.3559% | |
| -144.5163% | |
| -146.2994% |